These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14175297)

  • 41. EFFECTS OF LYSERGIC ACID DIETHYLAMIDE ON THE TOTAL LEUKOCYTES AND EOSINOPHILS OF THE FEMALE RAT.
    SACKLER AM; WELTMAN AS; SPARBER SB
    Nature; 1963 Sep; 199():1194-5. PubMed ID: 14072050
    [No Abstract]   [Full Text] [Related]  

  • 42. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 44. EXPERIMENTAL HYPERTHYROIDISM INDUCED BY CHRONIC LYSERGIC ACID BUTANOLAMIDE TREATMENT.
    MESS B; SZANTO L
    Acta Physiol Acad Sci Hung; 1964; 25():83-8. PubMed ID: 14196573
    [No Abstract]   [Full Text] [Related]  

  • 45. [HISTOCHEMICAL STUDIES ON THE BLOOD VESSELS OF THE INNER EAR].
    NAGAKURA M
    Nihon Jibiinkoka Gakkai Kaiho; 1964 Sep; 67():1251-71. PubMed ID: 14212218
    [No Abstract]   [Full Text] [Related]  

  • 46. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 47. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 48. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 49. SYNAPTIC TRANSMISSION IN THE HIPPOCAMPUS AND PSYCHOPHARMACOLOGICAL AGENTS.
    LIBERSON WT; KARCZMAR AG; SCHWARTZ E; ELLEN P
    Int J Neuropharmacol; 1963 Dec; 2():291-302. PubMed ID: 14119490
    [No Abstract]   [Full Text] [Related]  

  • 50. HISTOCHEMICAL LOCALIZATION OF RESPIRATORY AND OTHER HYDROLYTIC ENZYMES IN NEURONAL LIPOPIGMENT (LIPOFUSCIN) IN OLD GUINEA PIGS.
    KUMAMOTO T; BOURNE GH
    Acta Histochem; 1963 Sep; 16():87-100. PubMed ID: 14092273
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental psychopathological approach to the nature of auditory hallucination in schizophrenia].
    KATO K
    Seishin Shinkeigaku Zasshi; 1962 Sep; 64():998-1003. PubMed ID: 13958386
    [No Abstract]   [Full Text] [Related]  

  • 52. [KARYOMETRIC OBSERVATIONS ON AMPHICYTES IN THE SPINAL GANGLIA OF GUINEA PIGS. (WITH REMARKS ON THE HISTOLOGY AND HISTOCHEMISTRY OF GANGLIONIC CELLS AND AMPHICYTES)].
    MUNGYEROVA G
    Lek Pr; 1963; 3():1-57. PubMed ID: 14115034
    [No Abstract]   [Full Text] [Related]  

  • 53. [EFFECT OF NICOTINIC ACID ON EXPERIMENTAL PSYCHOSES INDUCED WITH LYSERGIC ACID DIETHYLAMIDE].
    IVANOVA RA; MILSHTEIN GI; SMIRNOVA LB; FANCHENKO ND
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1172-6. PubMed ID: 14244572
    [No Abstract]   [Full Text] [Related]  

  • 54. [PHARMACOLOGICAL STUDIES ON HALLUCINOGENS (2). 1. BIBLIOGRAPHICAL CONSIDERATIONS OF LSD25].
    MATSUOKA M
    Nihon Yakurigaku Zasshi; 1964 Jan; 60():88-103. PubMed ID: 14149858
    [No Abstract]   [Full Text] [Related]  

  • 55. EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON HIGHER NERVOUS ACTIVITY IN BABOONS.
    LAGUTINA NI; LARICHEVA KA; MILSHTEIN GI; NORKINA LN
    Fed Proc Transl Suppl; 1964; 23():737-40. PubMed ID: 14196918
    [No Abstract]   [Full Text] [Related]  

  • 56. EFFECTS OF SPINAL CORD AND SUBSTRATE ON ACETYLCHOLINESTERASE IN CHICK EMBRYONIC SKELETAL MUSCLE.
    GOODWIN BC; SIZER IW
    Dev Biol; 1965 Feb; 11():136-53. PubMed ID: 14300091
    [No Abstract]   [Full Text] [Related]  

  • 57. Catecholamines, monoamine oxidase and cholinesterase activity in the human sympathetic ganglion.
    Härkönen M; Penttilä A
    Acta Physiol Scand; 1971 Jul; 82(3):310-21. PubMed ID: 5127680
    [No Abstract]   [Full Text] [Related]  

  • 58. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.